Corporate Executives
Director
Akira Kurokawa
Representative Director of the Board, Chairman
- Corporate Management
- Life science business
- Understanding medical field and patients
Takeshi Ito
Representative Director of the Board, President and Chief Executive Officer
- Life science business
- Understanding medical field and patients
Kanoko Oishi
Director of the Board *
- Corporate management
- Understanding medical field and patients
- ESG and service to society
Yutaro Shintaku
Director of the Board *
- Corporate management
- Life science business
- Global leadership
Kunihito Minakawa
Director of the Board *
- Global leadership
- Finance and accounting
- Legal affairs and risk control
Noboru Kotani
Director of the Board *
- Corporate management
- Life science business
Tamie Minami
Director of the Board *
- Life science business
- Global leadership
- Outside Directors are independent officers as designed by the Tokyo Stock Exchange.
Corporate Auditor
Hiroshi Isaka
Standing Corporate Auditor
- Life science business
- Understanding medical field and patients
Masahiko Ikaga
Outside Auditor *
- Corporate management
- Finance and accounting
- Legal affairs and risk control
Junichi Asatani
Outside Auditor *
- Life science business
- Finance and accounting
- Legal affairs and risk control
Yaeko Hodaka
Outside Auditor *
- Global leadership
- Legal affairs and risk control
- ESG and service to society
- Outside Auditor are independent officers as designed by the Tokyo Stock Exchange.
Among skills respectively held, two or at most three skills, which are specifically advantageous or those with strong relevance to the businesses of Santen, are described.
- Corporate management
- Life science business
- Understanding medical field and patients
- Global leadership
- Finance and accounting
- Legal affairs and risk control
- ESG and service to society
Corporate Officers
| Chief Operating Officer, Head of North America Business | Rie Nakajima* |
| Head of Japan Business, Head of Japan Sales and Marketing Division, Head of Marketing Department | Ippei Kurihara* |
| Head of Europe, Middle East and Africa (EMEA) Business | Marianthi Psaha |
| Head of Sales Department, Japan Sales and Marketing Division | Shinichi Teramachi |
| Head of China Business | Takayuki Yamada |
| Chief Commercialization & Portfolio Officer | Chris Reindel |
| Global Head, Medical Tech Solutions Business Segment | Robert Wagner |
| Head of Sales and Marketing Division – OTC products | Yoshinori Watanabe |
| Head of Ophthalmology Innovation Center | Reza Haque* |
| Chief Medical Officer | Peter Sallstig* |
| Chief of Staff to CEO | Fumiyasu Ako* |
| Global Head of Business Development | Ken Araki* |
| Head of Supply Chain Division | Frank Binder |
| Chief Product Supply Officer | Mark Dawson* |
| Chief Digital & Information Officer | Minori Hara* |
| Chief Communications Officer | Nobuko Kato |
| Chief Financial Officer & Chief Risk Officer | Kazuo Koshiji* |
| General Counsel & Chief Compliance Officer | Mika Masunari* |
| Global Head of Core Principle & Sustainability | Takahiro Morita |
| Global Head of Corporate Strategy | Yoko Saiki* |
* Corporate Management Member (CMM)
Official SNS
